Summary
BM 12.531, the 2-[2-cyanaziridinyl-(1)]-2-[2-carbamoylaziridinyl-(1)]-propane, (prop. INN Azimexon), reduces significantly the acute toxicity of cyclophosphamide and X-rays in rats and mice, respectively. The leucopenia induced by X-rays was partially compensated by BM 12.531 in rats.
Similar content being viewed by others
References
U. Bicker, DL-PS 110492 (1974).
U. Bicker, Exp. Path.10, 106 (1975).
U. Bicker and P. Fuhse, Exp. Path.10, 279 (1975).
U. Bicker, G. Hebold, H. Hindermayr, U. Kampe and M. Thiel, DT-OS 2610 156 (1976).
U. Bicker, IRCS Med. Sci.5, 428 (1977).
U. Bicker, A.E. Ziegler and G. Hebold, IRCS Med. Sci.5, 299 (1977).
U. Bicker, G. Hebold and W. Maus, IRCS Med. Sci.5, 389 (1977).
B. Bonfert, U. Bicker, G. Hebold and W. Maus, IRCS Med. Sci.5, 523 (1977).
J.I. Schulz, I. Florentin, C. Bourut, U. Bicker and G. Mathé, IRCS Med. Sci.6, 215 (1978).
U. Bicker, Cancer Treatment Reports62, 1987 (1978).
U. Bicker, A.E. Ziegler and G. Hebold, J. infect. Dis.139, No 4 (1979).
U. Bicker, G. Hebold, A.E. Ziegler and W. Maus, Exp. Path.15, 49 (1978).
W. Stucky and J. Vollmar, J. Statist. Comput. Simul.5, 73 (1976).
J.D. Litchfield and F.W. Wilcoxon, J. Pharmac. exp. Ther.96, 99 (1949).
R. Braun, personal communication (1978).
Author information
Authors and Affiliations
Additional information
This work was supported by ‘Schutzkommission beim Bundesministerium des Innern’.
Rights and permissions
About this article
Cite this article
Bicker, U., Friedberg, K.D., Hebold, G. et al. Reduction of acute toxicity of cyclophosphamide and X-rays by the new immunomodulating compound BM 12.531. Experientia 35, 1361–1363 (1979). https://doi.org/10.1007/BF01964009
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01964009